BXRX
Baudax Bio, Inc. Common Stock
BXRX
BXRX
Delisted
BXRX was delisted on the 15th of November, 2023.
19 hedge funds and large institutions have $2.2M invested in Baudax Bio, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 8 increasing their positions, 2 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
19
Holding in Top 10
–
Calls
$80K
Puts
–
Top Buyers
| 1 | +$814K | |
| 2 | +$416K | |
| 3 | +$414K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$70.9K |
| 5 |
WAM
Warberg Asset Management
Winnetka,
Illinois
|
+$61K |
Top Sellers
| 1 | -$1.02M | |
| 2 | -$152K | |
| 3 | -$62K | |
| 4 |
AWA
Amplius Wealth Advisors
Blue Bell,
Pennsylvania
|
-$54K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$41K |